Finance

Lists
000403:SHE
Pacific Shuanglin Bio-pharmacy Co Ltd
CNÂ¥9.56
-1.04%
(-0.100) 1D
Oct 15, 3:04:42 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000403...
Open
CNÂ¥9.60
High
CNÂ¥9.68
Low
CNÂ¥9.47
Mkt. cap
9.22B
Avg. vol.
5.82M
Volume
4.65M
P/E ratio
34.01
52-wk high
CNÂ¥16.58
52-wk low
CNÂ¥8.54
EPS
CNÂ¥0.28
Shares outstanding
950.40M
No. of employees
3K
Open
CNÂ¥9.60
High
CNÂ¥9.68
Low
CNÂ¥9.47
Mkt. cap
9.22B
Avg. vol.
5.82M
Volume
4.65M
P/E ratio
34.01
52-wk high
CNÂ¥16.58
52-wk low
CNÂ¥8.54
EPS
CNÂ¥0.28
Shares outstanding
950.40M
No. of employees
3K
News stories
From web sources and news partners
About Pacific Shuanglin Bio-pharmacy Co Ltd
CEO-
Employees2.76K
Founded1993
Headquarters-
SectorBiotechnology
Website999yichun.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
631.66M
1.01B
342.92M
486.92M
Cost of goods sold
345.25M
674.87M
223.50M
333.55M
Cost of revenue
345.25M
674.87M
223.50M
333.55M
Research and development expenses
12.11M
25.01M
10.34M
6.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
142.84M
120.55M
83.99M
76.71M
Operating expense
161.42M
162.30M
98.57M
90.31M
Total operating expenses
506.67M
837.17M
322.07M
423.86M
Operating income
124.99M
177.29M
20.85M
63.06M
Other non operating income
-236.66K
-32.79K
-2.74M
2.22M
EBT including unusual items
138.01M
93.36M
29.08M
69.80M
EBT excluding unusual items
134.60M
178.56M
28.71M
70.38M
Income tax expense
16.43M
31.33M
6.34M
7.56M
Effective tax rate
11.90%
33.55%
21.82%
10.83%
Other operating expenses
5.57M
7.62M
6.17M
5.92M
Net income
121.39M
62.09M
22.97M
61.33M
Net profit margin
19.22%
6.12%
6.70%
12.60%
Earnings per share
-
-
-
-
Interest and investment income
15.61M
6.69M
15.52M
11.30M
Interest expense
-5.76M
-5.39M
-4.92M
-6.20M
Net interest expenses
9.85M
1.29M
10.60M
5.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
155.19M
210.35M
53.91M
100.07M
Gain or loss from assets sale
785.80K
-756.00K
-
135.62K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps